We found that the high expression of PLA2G16 was not only significantly associated with the alteration of immune cell composition in pancreatic cancer patients, but also suggested its potential immunomodulatory role in the tumor microenvironment (TME), which has not been reported before. This evidence concerns the gene PLAAT3 and neoplasm.